Valuation
- Market cap
- 5,449,000
- Revenue TTM
- $520,000
- Net income TTM
- $-5,100,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -980.77%
- Debt to equity
- 0.02
Trading
- Volume
- 16,100
- Avg volume
- 38,621
- Day's range
- $2.62 – $3.07
- Shares out
- 17,050,000
- Stochastic %K
- 40%
- Beta
- 2.81
- Analysts
- Strong Buy
- Price target
- —
Company profile
iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning sys...
Show more
iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 86 10 8496 6987
- Website
- https://www.ftzy.com.cn
- Address
- NET Building, Room 306 Hong Jun Ying South Road Chaoyang District, Beijing, China
Latest news
No headlines yet.
